These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 31916006)

  • 1. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
    Chow R; Valdez C; Chow N; Zhang D; Im J; Sodhi E; Lock M
    Support Care Cancer; 2020 May; 28(5):2095-2103. PubMed ID: 31916006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
    Smith LA; Azariah F; Lavender VT; Stoner NS; Bettiol S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009464. PubMed ID: 26561338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
    Todaro B
    J Natl Compr Canc Netw; 2012 Apr; 10(4):487-92. PubMed ID: 22491047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary and cumulative meta-analysis of olanzapine for antiemetic prophylaxis for chemotherapy-induced nausea and vomiting: do we still need to study its effectiveness?
    Chiu L; Chow R; DeAngelis C; Lock M; Simone CB
    Ann Palliat Med; 2021 Mar; 10(3):2540-2547. PubMed ID: 33440973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapeutic Considerations for Use of Cannabinoids to Relieve Symptoms of Nausea and Vomiting Induced by Chemotherapy.
    Serafimovska T; Darkovska-Serafimovska M; Stefkov G; Arsova-Sarafinovska Z; Balkanov T
    Folia Med (Plovdiv); 2020 Dec; 62(4):668-678. PubMed ID: 33415919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
    Alderman B; Hui D; Mukhopadhyay S; Bouleuc C; Case AA; Amano K; Crawford GB; de Feo G; Sbrana A; Tanco K; To J; Garsed J; Davis M
    Support Care Cancer; 2022 Dec; 31(1):39. PubMed ID: 36525085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
    Pergolizzi JV; Taylor R; LeQuang JA; Zampogna G; Raffa RB
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):467-477. PubMed ID: 28235999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability, and safety of cannabinoids for chemotherapy-induced nausea and vomiting--a systematic review of systematic reviews.
    Tafelski S; Häuser W; Schäfer M
    Schmerz; 2016 Feb; 30(1):14-24. PubMed ID: 26787227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting: a systematic review, meta-analysis, cumulative meta-analysis and fragility assessment of the literature.
    Chow R; Herrstedt J; Aapro M; Chiu L; Lam H; Prsic E; Lock M; DeAngelis C; Navari RM
    Support Care Cancer; 2021 Jul; 29(7):3439-3459. PubMed ID: 33442782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review.
    Chow R; Chiu L; Navari R; Passik S; Chiu N; Popovic M; Lam H; Pasetka M; Chow E; DeAngelis C
    Support Care Cancer; 2016 Feb; 24(2):1001-1008. PubMed ID: 26530228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
    Davis MP
    Expert Opin Investig Drugs; 2008 Jan; 17(1):85-95. PubMed ID: 18095921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the combination neurokinin-1 receptor antagonist, palonosetron, and dexamethasone compared to others for the prophylaxis of chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trials.
    Chow R; Tsao M; Chiu L; Popovic M; Milakovic M; Lam H; DeAngelis C
    Ann Palliat Med; 2018 Apr; 7(2):221-233. PubMed ID: 29764184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting: beyond prevention of acute emesis.
    Slatkin NE
    J Support Oncol; 2007 May; 5(5 Suppl 3):1-9. PubMed ID: 17566383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of olanzapine for the prophylaxis and rescue of chemotherapy-induced nausea and vomiting (CINV): a systematic review and meta-analysis.
    Chiu L; Chow R; Popovic M; Navari RM; Shumway NM; Chiu N; Lam H; Milakovic M; Pasetka M; Vuong S; Chow E; DeAngelis C
    Support Care Cancer; 2016 May; 24(5):2381-2392. PubMed ID: 26768437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic reviews.
    Schussel V; Kenzo L; Santos A; Bueno J; Yoshimura E; de Oliveira Cruz Latorraca C; Pachito DV; Riera R
    Phytother Res; 2018 Apr; 32(4):567-576. PubMed ID: 29168289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis.
    Machado Rocha FC; Stéfano SC; De Cássia Haiek R; Rosa Oliveira LM; Da Silveira DX
    Eur J Cancer Care (Engl); 2008 Sep; 17(5):431-43. PubMed ID: 18625004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review.
    Tramèr MR; Carroll D; Campbell FA; Reynolds DJ; Moore RA; McQuay HJ
    BMJ; 2001 Jul; 323(7303):16-21. PubMed ID: 11440936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness of ramosetron for preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis.
    Song HJ; Seo HJ; Son H
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1289-1301. PubMed ID: 27526189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are cannabinoids effective for the management of chemotherapy induced nausea and vomiting?
    Morales M; Corsi O; Peña J
    Medwave; 2017 Dec; 17(9):e7119. PubMed ID: 29286355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.